These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25348525)

  • 21. In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
    Xu J; Lu Y; Fu L; Zhu H; Wang B; Mdluli K; Upton AM; Jin H; Zheng M; Zhao W; Li P
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1119-25. PubMed ID: 22691726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
    Ollinger J; Kumar A; Roberts DM; Bailey MA; Casey A; Parish T
    PLoS One; 2019; 14(1):e0205479. PubMed ID: 30650074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
    Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A
    Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 30. The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis.
    Huang L; Kushner NL; Theriault ME; Pisu D; Tan S; McNamara CW; Petrassi HM; Russell DG; Brown AC
    Front Cell Infect Microbiol; 2018; 8():275. PubMed ID: 30155446
    [No Abstract]   [Full Text] [Related]  

  • 31. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 35. A high-throughput cidality screen for Mycobacterium tuberculosis.
    Kaur P; Ghosh A; Krishnamurthy RV; Bhattacharjee DG; Achar V; Datta S; Narayanan S; Anbarasu A; Ramaiah S
    PLoS One; 2015; 10(2):e0117577. PubMed ID: 25693161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis.
    Tansuphasiri U; Subpaiboon S; Rienthong S
    J Med Assoc Thai; 2001 Oct; 84(10):1467-76. PubMed ID: 11804258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 39. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary drug resistance in adult pulmonary tuberculosis].
    Porven G; Rodriguez EJ; Piccolo R
    Medicina (B Aires); 1973; 3(6):708-15. PubMed ID: 4217868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.